Table 5.

Flow chart of the patients included in the GIMEMA 0496 protocol




Clinical trial

Central handling

Evaluable integrated cytogenetic-molecular classification
No. patients eligible for the study   498   414   325  
No. patients who started induction   490   408   317  
No. patients evaluable for response   455   380   294  
No. RC (%)
 
363 (80)
 
303 (80)
 
232 (79)
 



Clinical trial

Central handling

Evaluable integrated cytogenetic-molecular classification
No. patients eligible for the study   498   414   325  
No. patients who started induction   490   408   317  
No. patients evaluable for response   455   380   294  
No. RC (%)
 
363 (80)
 
303 (80)
 
232 (79)
 

or Create an Account

Close Modal
Close Modal